// App-Quantinova.ai

808 : Blocking “don’t-eat-me” signal of CD47-SIRPα by anti-SIRPα antibody enhances anti-tumor efficacy of trastuzumab deruxtecan

Researchers

Presenter

  • Mayumi Sue

Principal Investigators

  • Takuya Tsubaki

  • Yoko Ishimoto

  • Shinko Hayashi

  • Saori Ishida

  • Yoshitaka Isumi

  • Jun Ishiguro

  • Reimi Kawaida

  • Toshiaki Ohtsuka

  • Teiji Wada

  • Toshinori Agatsuma

  • Norihito Kawasaki

Medical Centers

  • DAIICHI SANKYO, Tokyo, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • N/A

Drug/Treatment

  • Trastuzumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved